Teva Pharmaceutical Industries shares owned by Renaissance Technologies
Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Renaissance Technologies
from 13F filings
Historical chart of Renaissance Technologies investment in Teva Pharmaceutical Industries
Tip: Access up to 7 years of quarterly data
All positions including Teva Pharmaceutical Industries held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Teva Pharmaceutical Industries by Renaissance Technologies
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $146M | 8.1M | 18.02 |
2024-06-30 | $142M | 8.7M | 16.25 |
2024-03-31 | $109M | 7.7M | 14.11 |
2023-12-31 | $57M | 5.4M | 10.44 |
2023-09-30 | $41M | 4.0M | 10.20 |
2023-06-30 | $49M | 6.5M | 7.53 |
2023-03-31 | $58M | 6.5M | 8.85 |
2022-12-31 | $42M | 4.6M | 9.12 |
2022-09-30 | $35M | 4.3M | 8.07 |
2022-06-30 | $31M | 4.1M | 7.52 |
2022-03-31 | $24M | 2.6M | 9.39 |
2021-12-31 | $7.7M | 965k | 8.01 |
2021-09-30 | $349k | 36k | 9.75 |
2021-06-30 | $9.4M | 946k | 9.90 |
2020-09-30 | $10M | 1.1M | 9.01 |
2020-06-30 | $50M | 4.1M | 12.33 |
2020-03-31 | $29M | 3.2M | 8.98 |
2019-12-31 | $22M | 2.2M | 9.80 |
2019-09-30 | $48M | 6.9M | 6.88 |
2019-06-30 | $90M | 9.8M | 9.23 |
2019-03-31 | $41M | 2.6M | 15.68 |
2018-12-31 | $107M | 6.9M | 15.42 |
2018-09-30 | $75M | 3.5M | 21.54 |
2018-06-30 | $98M | 4.0M | 24.32 |
2018-03-31 | $15M | 901k | 17.09 |
2017-03-31 | $155M | 4.8M | 32.09 |
2016-12-31 | $79M | 2.2M | 36.25 |
2016-09-30 | $90M | 1.9M | 46.01 |
2016-06-30 | $70M | 1.4M | 50.23 |
2016-03-31 | $64M | 1.2M | 53.51 |
2015-12-31 | $35M | 533k | 65.64 |
2015-09-30 | $163M | 2.9M | 56.46 |
2015-03-31 | $83M | 1.3M | 62.30 |
2014-12-31 | $56M | 965k | 57.51 |
2014-09-30 | $14M | 265k | 53.75 |
2014-06-30 | $27M | 505k | 52.42 |
2013-06-30 | $12M | 298k | 39.20 |
Top funds holding Teva Pharmaceutical Industries
View all funds holding Teva Pharmaceutical Industries